Sygnis SA (WSE:SYG)
Poland · Delayed Price · Currency is PLN 1.180
+0.020 (1.72%)
At close: Aug 14, 2026
Sygnis Revenue
Sygnis had revenue of 1.97M PLN in the quarter ending June 30, 2026, a decrease of -41.72%. This brings the company's revenue in the last twelve months to 11.20M, up 26.13% year-over-year. In the year 2025, Sygnis had annual revenue of 11.33M with 15.65% growth.
Revenue (ttm)
11.20M
Revenue Growth
+26.13%
P/S Ratio
2.96
Revenue / Employee
n/a
Employees
13
Market Cap
38.50M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.33M | 1.53M | 15.65% |
| Dec 31, 2024 | 9.80M | -10.47M | -51.65% |
| Dec 31, 2023 | 20.27M | -8.01M | -28.33% |
| Dec 31, 2022 | 28.28M | 24.75M | 700.51% |
| Dec 31, 2021 | 3.53M | 765.22K | 27.65% |
| Dec 31, 2020 | 2.77M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.51B |
| Synektik Spólka Akcyjna | 932.97M |
| Voxel | 583.14M |
| BioMaxima | 59.74M |
| Pharmena | 1.61M |
| Nestmedic | 1.15M |
| Airway Medix | 89.00K |